renal/urinary system
• both males and females develop cystinuria
(J:254981)
|
|
(J:254803)
|
• males show smooth muscle hypertrophy and basement membrane thickening of varying degrees
|
• males develop cysteine stones in the kidney but to a lesser degree than in the bladder
|
• males exhibit partial bladder outlet obstruction due to bladder stones
|
• bladder weight of males is 4-fold higher than in controls and males exhibit an increase in bladder mass
|
• mice accumulate urinary bladder stones at an average rate of 1 mm3/day
(J:254803)
• mice treated with tiopronin, a sulfhydryl drug, or L-cystine dimethylester show no difference in cystine stone growth rate
(J:254803)
• treatment with the pro-antioxidant sulforaphane has a modest effect on cystine stone growth while treatment with alpha-lipoic acid strongly suppresses stone growth
(J:254803)
• males treated with alpha-lipoic acid before stone formation show delayed stone formation, lower overall stone volume accumulation, and form fewer stones
(J:254803)
• males treated with alpha-lipoic acid after forming stones show reduced growth rate of existing stones and withdrawal of alpha-lipoic acid results in reversion of stone growth rate
(J:254803)
• all males develop cysteine stones in the bladder, ranging in number of and size of stones
(J:254981)
• however, females do not exhibit bladder stones
(J:254981)
|
• intravesical pressure at capacity is lower in females but is normal in males
• both males and females show poor compliance (rate of intravesical pressure rise over the first 20% bladder volume) compared to controls, with males being worse than females
|
• both maximal contractile response and the rate of tension generation (contractile responses to neurogenic stimulation) are reduced in males, with mice responding between 20-30% of the response of controls
• the contractile responses to ATP (purinergic receptor agonist), KCl (smooth muscle membrane depolarization), and carbachol (muscarinic agonist) are also decreased in males
• females show slightly decreased contractile responses
• however, the contractile response to phenylephrine (alpha-adrenergic agonist) is normal
|
• the volume at capacity of bladder is lower in males
• females exhibit increased volume compared to males
|
• females exhibit decreased voiding pressure
|
homeostasis/metabolism
• both males and females develop cystinuria
(J:254981)
|
|
(J:254803)
|
muscle
• males show smooth muscle hypertrophy and basement membrane thickening of varying degrees
|
• both maximal contractile response and the rate of tension generation (contractile responses to neurogenic stimulation) are reduced in males, with mice responding between 20-30% of the response of controls
• the contractile responses to ATP (purinergic receptor agonist), KCl (smooth muscle membrane depolarization), and carbachol (muscarinic agonist) are also decreased in males
• females show slightly decreased contractile responses
• however, the contractile response to phenylephrine (alpha-adrenergic agonist) is normal
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
cystinuria | DOID:9266 |
OMIM:220100 |
J:254803 , J:254981 |